Science and Technology - Fifth Report - Appendices to the Minutes of Evidence [Back to Report]

---

Here you can browse the report which was ordered by the House of Commons to be printed 13 August 1998.

CONTENTS



Terms of Reference

APPENDICES TO THE MINUTES OF EVIDENCE

APPENDIX 1

Letter to the Clerk of the Committee from Mr J Wilson Carswell OBE
Annex 1

Letter to Mr Simon Brickles, Regulator Manager, AIM, from Mr J Wilson Carswell OBE

APPENDIX 2

Memorandum submitted by Cameron McKenna

SCOPE OF OUR INSTRUCTIONS
PREPARATION OF OUR REPORT
CONCLUSIONS IN OUR REPORTS
WIDER ISSUES

APPENDIX 3

Memorandum submitted by the London Stock Exchange

1. INTRODUCTION
2. CONFIDENTIALITY
3. COMPETENT AUTHORITY INVESTIGATION OF BRITISH BIOTECH
4. ASSESSMENT OF IMPACT ON THE BIOTECHNOLOGY INDUSTRY

Annex

BRITISH BIOTECH PLC

Graph Comparing Performance of British Biotech Compared with the FTSE All Share And UK Biotech Indices

APPENDIX 4

Memorandum submitted by Mercury Asset Management Ltd

INTRODUCTION
CONTENTS
CLINICAL STRATEGY
CORPORATE STRATEGY
SHARE DEALING

APPENDIX 5

Letter to Dr Ian Gibson MP from Dr James Noble, former Finance Director, British Biotech plc
1. NON-EXECUTIVE DIRECTORS
2. KLEINWORT BENSON
3. OVERALL

Annex

Letter to Dr Keith McCullagh, Chief Executive Officer British Biotech plc from Dr L John Wilkerson

---

---

Prepared 13 October 1998